BUSINESS● LOW21h ago · Oct 14, 2026, 9:06 AM
Aurobindo joins speciality pharma race as Indian drugmakers return to branded US play
moneycontrol · india · global
Aurobindo's speciality push is being led through Acrotech Biopharma, a step-down subsidiary focused on innovative and proprietary medicines
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from india
POLITICS1h agoIndia news: Supreme Court likely to hear Rahul Gandhi's Election Commision pleaDW News [en]SCI & TECH2h agoIn 1996, Indiana transformed residual foundry sand into a 275-meter road embankment; subsequently, Purdue discovered that the material successfully worked as a large-scale road fillerClarínWORLD2h agoIndia’s largest red light area in Kolkata’s Sonagachi inaugurates Durga PujaThe HinduPOLITICS2h agoIndia asks when UN body will report on PoK human rights concernsThe Hindu
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS36m agoTaiwan Semiconductor Manufacturing Company declares NT$7.00 quarterly dividendSeeking Alpha TechBUSINESS37m agoAI job losses set to rein in office demand in developed Asia-Pacific economies: reportSouth China Morning Post